Wendy Armstrong
Overview
Wendy Armstrong MD FIDSA received her MD from Harvard Medical School and completed her Internal Medicine residency and Infectious Diseases (ID) fellowship at the University of Michigan. She joined the Emory University Division of Infectious Disease in 2007 and is now Professor of Medicine, Interim Division Director for ID and Executive Medical Director of the Ponce de Leon Center, Infectious Diseases Program (IDP) at Grady Health System. The Ponce Center is a Ryan White funded program that provides comprehensive care to more than 8000 persons living with HIV in the Atlanta metro area. She was the Vice Char of Education and Integration for the Department of Medicine for 11 years and the Program Director of the ID Fellowship Training Program for 17 years.
Dr. Armstrong is a past chair of the HIV Medicine Association (HIVMA) and has served on the IDSA Board of Directors. She is currently the Vice President of the Infectious Disease Society of America (IDSA) Board of Directors, is chair of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) and is the CHAC representative to the Presidents Advisory Council on HIV/AIDS.
Academic Appointment
- Associate Director, Division of Infectious Diseases, Emory University School of Medicine
- Master Clinician, Emory University School of Medicine
- Vice Chair of Education and Integration, Emory University Department of Medicine, Emory University School of Medicine
- Professor of Medicine, Division of Infectious Diseases, Emory University Department of Medicine, Emory University School of Medicine
Education
Degrees
- MD from 1989-1994 Harvard Medical School
- AB from 1985-1989 Washington University
Research
Publications
-
Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine.
Open Forum Infect Dis Volume: 12 Page(s): ofaf104
04/01/2025 Authors: Metsch LR; Feaster DJ; Gooden LK; Pan Y; Parish CL; Waldrop D; Rodriguez A; Colasanti JA; Armstrong WS; Root C -
Enhancing Hepatitis B Virus Vaccine Uptake and Immunity Through Long-Acting Antiretroviral Therapy Programmatic Synergy in the US South.
Open Forum Infect Dis Volume: 12 Page(s): ofaf096
03/01/2025 Authors: Ochieng E; Robinson V; Anderson E; Niles-Carnes L; Smith BL; Armstrong WS; Lora M; Colasanti JA; Collins LF -
Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South.
AIDS Res Hum Retroviruses Volume: 40 Page(s): 690 - 700
12/01/2024 Authors: Haser GC; Balter L; Gurley S; Thomas M; Murphy T; Sumitani J; Leue EP; Hollman A; Karneh M; Wray L -
Human Immunodeficiency Virus in the South: An Epidemic Within an Epidemic.
Infect Dis Clin North Am Volume: 38 Page(s): 581 - 598
09/01/2024 Authors: Saldana CS; Armstrong WS -
Ending the HIV Epidemic in Metropolitan Atlanta: a mixed-methods study to support the local HIV/AIDS response.
J Int AIDS Soc Volume: 27 Page(s): e26322
07/01/2024 Authors: Piske M; Nosyk B; Smith JC; Yeung B; Enns B; Zang X; Sullivan PS; Armstrong WS; Thompson MA; Daniel G -
Skills, Not Just Knowledge: Infectious Diseases Fellows' Recommendations Regarding Antimicrobial Stewardship Training.
Clin Infect Dis Volume: 77 Page(s): 1265 - 1272
11/11/2023 Authors: Wasson MK; Luther VP; Armstrong WS; Schwartz BS; Shnekendorf R; Logan A; Bennani K; Spicer JO -
The CARES Program: Improving Viral Suppression and Retention in Care Through a Comprehensive Team-Based Approach to Care for People with HIV and Complex Psychosocial Needs.
AIDS Patient Care STDS Volume: 37 Page(s): 416 - 424
08/01/2023 Authors: Sweitzer S; Giegold M; Chen Y; Farber EW; Sumitani J; Henderson A; Easley K; Armstrong WS; Colasanti JA; Ammirati RJ -
Principles for Ending Human Immunodeficiency Virus as an Epidemic in the United States: A Policy Paper of the Infectious Diseases Society of America and the HIV Medical Association.
Clin Infect Dis Volume: 76 Page(s): 1 - 9
01/06/2023 Authors: Person AK; Armstrong WS; Evans T; Fangman JJW; Goldstein RH; Haddad M; Jain MK; Keeshin S; Tookes HE; Weddle AL -
The association between comorbidities and coronavirus disease 2019 hospitalization among people with HIV differs by age.
AIDS Volume: 37 Page(s): 71 - 81
01/01/2023 Authors: Moran CA; Oliver NT; Szabo B; Collins LF; Nguyen MLT; Shah NS; Moanna A; Colasanti JA; Cantos VD; Armstrong WS -
Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South.
Open Forum Infect Dis Volume: 9 Page(s): ofac455
09/01/2022 Authors: Collins LF; Corbin-Johnson D; Asrat M; Morton ZP; Dance K; Condra A; Jenkins K; Todd-Turner M; Sumitani J; Smith BL